Sexual activity and cardiovascular risk;Cinsel aktivite ve kardiyovasküler risk

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue 4, 2007, Pages 423-426

  Boztosun, Bilal ^a,c   Olcay, Ayhan ^b   Deǧertekin, Muzaffer ^a  

^a Kardiyoloji Bölümü ^*  (Turkey)

^b Istanbul Science University   (Turkey)

^c Merkez Mah   (Turkey)

Author keywords

Cardiovascular event; Sexual function

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CERIVASTATIN; DIGITOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; FELODIPINE; FIBRINOLYTIC AGENT; ISRADIPINE; LOSARTAN; MEVINOLIN; MIBEFRADIL; NEW DRUG; NIFEDIPINE; PHOSPHODIESTERASE V INHIBITOR; QUINIDINE; SILDENAFIL; SIMVASTATIN; VERAPAMIL;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ERECTILE DYSFUNCTION; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART INFARCTION; HUMAN; IMPOTENCE; LIFE EXPECTANCY; MORTALITY; REHABILITATION CARE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SUDDEN DEATH; TRANSLUMINAL CORONARY ANGIOPLASTY; TURKEY (REPUBLIC);

HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS; SEXUALITY; SURVIVORS;

EID: 37349063720     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001 May; 156: 1-10.
2. Ruigomez A, Johansson S, Wallander MA, Garcia Rodriguez LA. Gender and drug treatment as determinants of mortality in a cohort of heart failure patients. Eur J Epidemiol 2001; 17: 329-35.
3. Yildiz H, Pinar R. Miyokard infarktüslü hastalarda cinsel disfonksiyon. Anadolu Kardiyol Derg 2004; 4: 309-17.
4. Türk Kardiyoloji Darneǧi. Kalp damar hastaliklarinda erektil disfonksiyon durum raporu. Istanbul: Türk Kardiyoloji Derneǧi 2000.
5. Kekilli M, Beyazit Y, Purnak T, Dogan S, Atalar E. Acute myocardial infarction after sildenafil citrate ingestion. Ann Pharmacother 2005; 39: 1362-4.
6. Parzeller M, Raschka C, Bratzke H. Sudden cardiovascular death in correlation with sexual activity: results of a medicolegal postmortem study from 1972-1988. Eur Heart J 2001: 22; 610-1.
7. Bernardo A. Sexuality in patients with coronary disease and heart failure. Herz 2001; 26: 353-9.
8. Skinner JS. Sexual relation. In: Pollock ML, Schmidt DH, editors. Heart Disease and Rehabilitation. 3rd ed. Champaign, IL: Human Kinetics Publishers; 1895. p.367-78.
9. Nemec ED, Mansfield L, Kennedy JW. Heart rate and blood pressure responses during sexual activity in normal males. Am Heart J 1976; 92: 274-7.
10. Seidl A, Bullough B, Haughey B, Scherer Y. Understanding the effects of a myocardial infarction on sexual functioning: a basis for sexual counseling. Rehabil Nurs 1991; 16: 255-64.
11. Persson G. Five-year mortality in a 70-year old urban population in relation to psychiatric diagnosis, personality, sexuality and early parental death. Acta Psychiatr Scand 1981; 64: 244-53.
12. Abramov LA. Sexual life and frigidity among women: findings from the nun study. J Gerontol Ser B 1998; 51 Suppl: S201-8.
13. Smith GD, Frankel S, Yarnell J. Sex and death: Are they related? Findings from the Caerphilly cohort study. BMJ 1997; 315: 1641-4.
14. Pollock ML SD. Heart Disease and Rehabilitation. 3rd ed. Champaign, III: Human Kinetics; 1995.
15. Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, et al. Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation 1999; 99: 168-77.
16. Papadopoulos C. Cardiovascular drugs and sexuality: a cardiologist's review. Arch Intern Med 1980 Oct; 140: 1341-5.
17. Smith PJ, Talbert RL. Sexual dysfunction with antihypertensive and antipsychotic agents. Clin Pharm 1986; 5: 373-84.
18. Stokes GS, Mennie BA, Gellatly R, Hill A. On the combination of alpha- and beta-adrenoreceptor blockade in hypertension. Clin Pharmacol Ther 1983; 34: 576-82.
19. Silvestri A, Galetta P, Cerquetani E, Marazzi G, Patrizi R, Fini M, et al. Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo. Eur Heart J 2003; 24: 1928-32.
20. Carvajal A, Lerida MT, Sanchez A, Martin LH, de Diego IM. ACE inhibitors and impotence; a case series from the Spanish drug monitoring system. Drug Saf 1995; 13: 130-1.
21. Product information: Cozaar ® Losartan. West Point, PA: Merck&Co, Inc; 1998.
22. Vlachopoulos C, Aznaouridis K, Ioakeimidis N, Rokkas K, Vasiliadou C, Alexopoulos N, et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 2006; 27: 2640-8.
23. Muller JE, Mittleman MA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by sexual activity. JAMA 1996; 275: 1405-9.
24. Kloner RA, Jarow JP. Erectile dysfunction and sildenafil citrate and cardiologists. Am J Cardiol 1999; 83: 576-82.
25. Kaplan SA, Reis RB, Kohn IJ, Ikeguchi EF, Laor E, Te AE, et al. Safety and efficacy of sildenafil in postmenopausal woman with sexual dysfunction. Urology 1998; 53: 481-6.
26. Zusman RM, Prisant LM, Brown MJ. Effect of sildenafil citrate on blood pressure and heart rate in man with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group. J Hypertens 2000; 18: 1865-9.
27. Kloner RA, Brown M, Prisant LM, Collins M. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil Study Group. Am J Hypertens 2001; 14: 70-3.
28. Pickering TG, Shepherd AM, Puddey I, Glasser DB, Orazem J, Sherman N, et al. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. Am J Hypertens 2004; 17: 1135-42.
29. Kloner RA, Mohan P, Sagerson T. Cardiovascular safety of vardenafil in patients receiving antihypertensive medications: a post-hoc analysis of five placebo-controlled trials. J Am Coll Cardiol 2003; 41 (suppl A): 276A-7A.
30. Kloner RA, Mitchell M, Emmick JT. Cardiovascular effects of tadalafil in patients on common antihypertensive therapies. Am J Cardiol 2003; 92 Suppl: 47M-57M.
31. Sildenafil prescribing information. New York, NY: Pfizer; 2004.
32. Product monograph for Levitra (vardenafil HCL). Bayer Health Care, Glaxo SmithKline; 2003.
33. Kloner RA. Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation 2004; 110: 3149-55.
34. Alboni P, Bettiol K, Fuca G, Pacchioni F, Scarfo S. Sexual activity with and without the use of sildenafil: risk of cardiovascular events in patients with heart disease. Ital Heart J 2004 May; 5: 343-9.
35. Cheitlin MD, Hutter AM Jr, Brindis RG, Ganz P, Kaul S, Russell RO Jr, et al. ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/ American Heart Association. J Am Coll Cardiol 1999; 33: 273-82.
36. Simonsen U. Interactions between drugs for erectile dysfunction and drugs for cardiovascular disease. Int J Impot Res 2002; 14: 178-88.
37. DeBusk RF, Drory Y, Goldstein I, Jackson G, Kaul S, Kimmel SE, et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000; 86: 175-81.
38. Giugliano D, Giugliano F, Esposito K. Sexual dysfunction and the Mediterranean diet. Public Health Nutr 2006; 9: 1118-20.